ten
year
ago
interferon
ifn
discov
two
independ
group
form
type
iii
ifn
famili
compos
three
member
also
name
respect
recent
fourth
subtyp
name
describ
human
express
small
fraction
human
popul
consequ
frameshift
occur
code
sequenc
upstream
gene
ifn
bear
ident
act
receptor
display
typic
antivir
activ
gene
encod
map
chromosom
human
mice
mice
pseudogen
unlik
type
ifn
gene
intronless
type
iii
ifn
sever
exon
human
shown
nglycosyl
contain
potenti
nglycosyl
site
mice
nglycosyl
type
iii
ifn
signal
heterodimer
cell
surfac
receptor
compos
two
chain
specif
share
cytokin
type
ifn
use
differ
receptor
ifnar
compos
subunit
howev
upon
bind
cognat
receptor
type
type
iii
ifn
trigger
jakstat
signal
transduct
pathway
fig
lead
upregul
mani
gene
call
ifnstimul
gene
isg
review
isg
identifi
product
act
control
viral
infect
modul
immun
respons
control
mitosi
addit
isg
encod
factor
particip
ifn
signal
transduct
pathway
therefor
control
ifn
express
respons
posit
neg
feedback
loop
fig
type
type
iii
ifn
receptor
express
singl
cell
line
trigger
either
receptor
complex
lead
upregul
set
isg
therefor
major
question
aros
discoveri
whether
type
type
iii
ifn
respons
redund
vivo
one
first
evidencebas
studi
report
antivir
activ
vivo
publish
ank
et
al
observ
intravagin
treatment
femal
mice
prior
infect
herp
simplex
viru
hsv
prevent
viru
replic
vagin
mucosa
next
analysi
antivir
activ
vivo
larg
benefit
develop
receptordefici
mice
compar
viral
infect
wildtyp
doubleknockout
mice
shown
contribut
control
viral
infect
greatli
vari
accord
viru
tabl
figur
recapitul
current
avail
data
spite
efficaci
treatment
observ
defici
substanti
affect
replic
contrast
defici
strongli
increas
replic
thu
efficaci
infect
vivo
modest
compar
type
ifn
addit
studi
show
protect
effect
infect
encephalomyocard
viru
lymphocyt
choriomening
viru
vesicular
stomat
viru
similarli
antivir
activ
could
detect
mice
hepatotrop
virus
rift
valley
fever
viru
lassa
fever
viru
mutant
strain
thogoto
viru
thov
lack
ifnantagonist
ml
protein
lack
antivir
activ
virus
due
lack
express
infect
organ
sinc
transcript
activ
liver
mice
infect
yet
spite
express
thov
rift
valley
fever
viru
fail
induc
express
infect
liver
mx
mice
lack
function
type
ifn
receptor
found
modest
detect
antivir
activ
vivo
influenza
viru
human
metapneumoviru
sever
acut
respiratori
syndrom
coronaviru
virus
mice
lack
receptor
turn
significantli
suscept
mice
addit
studi
carri
influenza
viru
show
variabl
extent
protect
mediat
two
studi
report
moder
import
influenza
viru
strain
blee
one
studi
observ
major
role
strain
differ
influenza
viru
control
might
relat
variat
abil
differ
viru
strain
spread
system
respiratori
epithelium
contribut
much
clearer
case
respiratori
syncyti
viru
inde
control
respiratori
syncyti
viru
infect
depend
equal
presenc
type
type
iii
ifn
receptor
interestingli
shown
play
major
nonredund
role
protect
rotaviru
infect
doubleknockout
mice
highli
suscept
oral
rotaviru
infect
wildtyp
mice
resist
moreov
administr
allow
control
rotaviru
infect
mice
administr
thu
appear
contribut
much
type
ifn
protect
rotaviru
unlik
type
ifn
receptor
ubiquit
express
type
iii
ifn
receptor
especi
chain
display
much
restrict
cellular
distribut
sever
studi
examin
respons
human
mous
cell
line
primari
cell
tabl
unsurprisingli
respons
correl
express
fibroblast
splenocyt
bonemarrowderiv
macrophag
endotheli
cell
respond
although
respond
contrast
mous
melanoma
cell
keratinocyt
respond
studi
demonstr
epitheli
cell
primari
target
type
iii
ifn
analysi
express
isol
mous
cell
reveal
keratinocyt
vagin
epitheli
cell
fibroblast
respons
first
vivo
studi
express
mice
perform
laboratori
studi
respons
circul
evalu
vivo
variou
mous
organ
plasmidmedi
express
tibiali
muscl
cell
tissu
show
highest
respons
stomach
intestin
skin
lung
epitheliumrich
organ
moreov
respons
parallel
express
analyz
tissu
studi
respons
analyz
cellular
level
kidney
brain
section
use
immunohistofluoresc
detect
specif
marker
ifn
respons
cell
strikingli
differ
cell
express
cell
almost
exclus
correspond
epitheli
cell
includ
cell
form
convolut
tubul
kidney
epitheli
cell
plexu
brain
contrast
circul
induc
widespread
respons
pronounc
endotheli
cell
includ
cell
type
epitheli
cell
specif
respons
subsequ
observ
mani
organ
lung
intestin
stomach
skin
liver
fig
human
constitut
express
also
observ
upper
epidermi
epitheli
specif
respons
fit
observ
antivir
activ
ifn
mous
infect
model
high
impact
observ
rotaviru
infect
good
agreement
tropism
exhibit
viru
toward
intestin
epitheli
cell
noteworthi
lack
antivir
activ
observ
virus
may
stem
use
intraperiton
inocul
tabl
expect
bypass
barrier
made
epitheli
respons
thu
express
narrow
rang
cell
type
mainli
epitheli
cell
howev
respons
also
report
nonepitheli
cell
notabl
blood
cell
among
cell
convent
cdc
plasmacytoid
dendrit
cell
pdc
express
shown
alter
stimulatori
properti
b
cell
monocyt
also
express
low
signific
level
fail
show
detect
respons
express
detect
natur
killer
cell
hepatocyt
abund
cell
liver
target
sever
virus
epitheli
natur
hepatocyt
expect
respond
human
hepatocyt
cell
line
primari
human
hepatocyt
inde
express
receptor
readili
respond
accordingli
shown
restrict
hcv
replic
hepatoma
cell
line
clinic
studi
conduct
enter
phase
clinic
trial
candid
drug
hcv
infect
contrast
mice
respons
appear
weak
liver
express
hardli
detect
organ
moreov
mous
infect
experi
protect
hepatotrop
virus
lassa
fever
viru
thov
rift
valley
fever
viru
despit
document
product
liver
infect
mice
also
transgen
mice
harbor
genom
hepat
b
viru
much
less
potent
reduc
viral
replic
data
suggest
respons
strongli
differ
human
mous
hepatocyt
model
chimer
mice
engraft
human
hepatocyt
gene
encod
strongli
express
human
mous
hepatocyt
data
support
observ
show
human
mous
hepatocyt
respond
chimer
mice
treat
mous
liver
respons
limit
cholangiocyt
epitheli
cell
form
bile
duct
case
type
ifn
dc
particularli
pdc
shown
import
produc
upon
viral
infect
parapoxviru
sendai
viru
pdc
produc
larg
amount
howev
report
respons
polyinosin
polycytidyl
acid
poli
c
murin
dc
subset
cdc
major
cell
popul
produc
anoth
studi
report
human
cdc
counterpart
murin
dc
major
cell
popul
produc
treatment
poli
c
cocultur
hcvinfect
cell
interestingli
releas
detect
cell
conclus
pdc
cdc
produc
fact
cell
cdc
produc
stimul
hcvinfect
cell
illustr
subtl
differ
exist
pathway
lead
type
type
iii
ifn
product
epitheli
cell
main
target
activ
interestingli
sever
studi
suggest
epitheli
cell
may
also
act
cell
instanc
major
ifn
type
induc
rhinoviru
influenza
viru
infect
primari
human
airway
epitheli
cell
mice
product
observ
mous
tracheal
epitheli
cell
respons
influenza
viru
infect
poli
c
treatment
product
also
report
cultur
primari
human
keratinocyt
respons
poli
c
treatment
vesicular
stomat
viru
infect
interestingli
type
ifn
detect
low
level
cell
hepatocyt
also
produc
mrna
express
induc
respons
experiment
hcv
infect
human
fetal
liver
cell
patient
chronic
hcv
infect
recent
model
chimer
mice
transplant
human
hepatocyt
report
express
produc
human
hepatocyt
greater
level
respons
poli
c
treatment
interestingli
studi
human
express
strongli
induc
cell
cell
kidney
fibroblast
cell
line
respect
wherea
opposit
pattern
observ
express
mice
although
liver
proven
weakli
respons
ifn
readili
express
respons
viru
infect
final
also
shown
produc
follow
bacteri
infect
listeria
monocytogen
vivo
placenta
infect
mice
vitro
human
intestin
cell
line
trophoblast
cell
cell
sever
isg
encod
factor
like
riglik
helicas
tlr
particip
signal
transduct
pathway
lead
ifn
product
isg
encod
protein
like
soc
posit
neg
modul
ifn
respons
sinc
type
type
iii
ifn
use
similar
signal
transduct
pathway
upregul
group
isg
expect
cross
talk
exist
two
ifn
system
fig
inde
type
iii
ifn
express
shown
upregul
type
ifn
condit
viru
infect
report
differ
research
group
cdc
macrophag
treatment
prior
viru
infect
increas
express
result
obtain
macrophag
stimul
tlr
agonist
furthermor
cocultur
peripher
blood
mononuclear
cell
hcvinfect
hepatoma
cell
zhang
et
al
observ
increas
secret
treatment
conclus
activ
type
ifn
respons
clearli
prime
cell
product
mice
virusinduc
express
thu
expect
lower
wildtyp
mice
inde
observ
mice
infect
sendai
viru
influenza
viru
less
evid
accumul
show
type
iii
ifn
modul
type
ifn
express
pretreat
monocytederiv
macrophag
mddc
enhanc
mrna
express
likewis
treatment
peripher
blood
mononuclear
cell
pdc
cocultur
hcvinfect
cell
enhanc
product
contrast
two
studi
fail
show
activ
type
ifn
pathway
infect
sendai
viru
splenocyt
deriv
mice
produc
less
type
type
iii
ifn
splenocyt
deriv
wildtyp
mice
also
treatment
human
airway
epitheli
cell
infect
influenza
increas
express
howev
neg
result
interpret
follow
first
case
cell
splenocyt
popul
expect
respond
therefor
modul
type
ifn
express
second
case
epitheli
cell
airway
epitheli
cell
like
poor
produc
irrespect
prime
ifn
conclus
cross
talk
exist
type
type
iii
ifn
system
like
depend
abil
cell
produc
respond
specif
ifn
type
type
ifn
use
treat
diseas
chronic
viral
hepat
multipl
sclerosi
howev
treatment
side
effect
might
partli
relat
ubiquit
express
ifnar
contrast
receptor
distribut
restrict
reason
fewer
side
effect
may
expect
use
cultur
cell
liver
shown
repeat
stimul
lead
nonrespons
cell
refractori
believ
one
reason
lack
respons
hcvinfect
patient
treatment
interestingli
induc
refractori
state
liver
cell
might
thu
better
adapt
repeat
treatment
discuss
human
hepatocyt
appear
respons
clinic
trial
use
recombin
current
ongo
treatment
chronic
hcv
infect
phase
clinic
trial
publish
studi
subject
chronic
hcv
genotyp
administ
pegyl
ifn
pegifn
without
ribavirin
well
toler
antivir
activ
hcv
side
effect
aminotransferas
lipas
amylas
elev
report
advers
event
includ
fatigu
nausea
myalgia
headach
report
seem
less
frequent
therapi
importantli
signific
hematolog
toxic
detect
phase
studi
publish
abstract
milder
side
effect
confirm
enter
phase
clinic
trial
genomewid
associ
studi
identifi
singl
nucleotid
polymorph
snp
region
gene
human
tabl
snp
locat
kb
upstream
respect
associ
respons
hcv
patient
cotreat
ribavirin
spontan
hcv
clearanc
allel
associ
treatment
failur
patient
european
ancestri
c
allel
associ
twofold
greater
rate
sustain
virolog
respons
interestingli
ge
et
al
identifi
two
addit
snp
gene
snp
highli
associ
consist
substitut
bp
upstream
start
codon
occur
open
read
frame
result
nonsynonym
amino
acid
chang
posit
arginin
substitut
lysin
sinc
snp
identifi
region
gene
associ
sustain
virolog
respons
therapi
howev
mechan
polymorph
affect
efficaci
hcv
clearanc
remain
determin
recent
novel
transcript
locat
kb
upstream
identifi
snp
locat
within
intron
newli
identifi
gene
novel
marker
detect
exon
dinucleotid
variant
result
delet
one
nucleotid
substitut
variant
creat
frameshift
allow
express
protein
paradox
express
addit
subtyp
associ
impair
clearanc
hcv
although
shown
exhibit
potent
inhibitori
effect
hcv
replic
vitro
moreov
express
often
correl
express
allel
also
predictor
low
virolog
respons
hcv
treatment
given
associ
snp
locu
spontan
drugmedi
viral
clearanc
hcv
genotyp
patient
help
defin
therapeut
strategi
viru
evid
accumul
show
type
type
iii
ifn
system
larg
nonredund
induc
longer
activ
repeat
stimul
cell
lead
refractori
cell
subsequ
stimul
importantli
vivo
express
pattern
receptor
clearli
diverg
receptor
respons
predominantli
observ
epitheli
cell
although
hematopoiet
cell
also
shown
respons
thu
like
evolv
protect
mucos
surfac
viral
infect
ifn
famili
probabl
utter
import
virus
strong
epitheli
tropism
demonstr
case
rotaviru
worth
note
recent
studi
show
epitheli
cell
also
act
cell
system
thu
like
evolv
offer
local
protect
fit
epitheliumrich
anatom
structur
gastrointestin
respiratori
tract
fig
protect
epitheli
surfac
may
also
instrument
limit
viru
transmiss
fecoor
aerosol
transmiss
reduc
viru
excret
viru
entri
signal
transduct
pathway
lead
product
close
resembl
lead
type
ifn
product
yet
studi
suggest
cell
produc
type
type
iii
ifn
fulli
overlap
studi
requir
address
issu
recent
eleg
model
report
mous
develop
identifi
cell
mice
one
allel
region
replac
firefli
luciferasecod
region
allow
immunostain
vivo
imag
cell
develop
model
monitor
express
vivo
would
particularli
valuabl
complet
understand
peculiar
system
summari
characterist
type
iii
ifn
render
attract
target
antivir
therapi
phase
clinic
trial
current
ongo
test
use
therapi
chronic
hcv
interestingli
number
polymorph
identifi
region
gene
shown
influenc
outcom
treatment
hcv
new
subtyp
describ
implic
impair
clearanc
hcv
patient
express
gene
understand
underli
mechan
variat
respons
treatment
help
improv
therapi
